CD44 and breast carcinoma: Consistently, TNBC is histologically poorly differentiated and displays enhanced stemness compared to other breast cancer subtypes, as evidenced by a higher proportion of CD44+CD24− and ALDH+ breast cancer stem cells (BCSCs) [6–8].